These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27369376)

  • 1. High-resolution mass spectrometry in toxicology: current status and future perspectives.
    Maurer HH; Meyer MR
    Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyphenated high-resolution mass spectrometry-the "all-in-one" device in analytical toxicology?
    Maurer HH
    Anal Bioanal Chem; 2021 Apr; 413(9):2303-2309. PubMed ID: 33247339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?
    Meyer MR; Maurer HH
    Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current applications of high-resolution mass spectrometry in drug metabolism studies.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 May; 403(5):1221-31. PubMed ID: 22349341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review.
    Pasin D; Cawley A; Bidny S; Fu S
    Anal Bioanal Chem; 2017 Oct; 409(25):5821-5836. PubMed ID: 28634759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Maurer HH
    Anal Bioanal Chem; 2007 Aug; 388(7):1315-25. PubMed ID: 17377775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
    Maurer HH
    J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
    Wu AH; Colby J
    Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of liquid chromatography--mass spectrometry in analytical toxicology: a review.
    Hoja H; Marquet P; Verneuil B; Lotfi H; Pénicaut B; Lachâtre G
    J Anal Toxicol; 1997; 21(2):116-26. PubMed ID: 9083829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.
    Meyer MR; Helfer AG; Maurer HH
    Bioanalysis; 2014 Aug; 6(17):2275-84. PubMed ID: 25383737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(1):195-208. PubMed ID: 21866399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology.
    Meyer GM; Maurer HH; Meyer MR
    Bioanalysis; 2016; 8(5):457-81. PubMed ID: 26924594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New challenges and innovation in forensic toxicology: focus on the "New Psychoactive Substances".
    Favretto D; Pascali JP; Tagliaro F
    J Chromatogr A; 2013 Apr; 1287():84-95. PubMed ID: 23332303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical toxicology.
    Maurer HH
    EXS; 2010; 100():317-37. PubMed ID: 20358688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology.
    Maurer HH
    Ther Drug Monit; 2018 Aug; 40(4):389-393. PubMed ID: 29750739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.